Suppr超能文献

含有1-氧化-2-吡啶基取代2-硝基苯基部分的硝苯地平类似物的合成及钙通道拮抗剂活性

Synthesis and calcium channel antagonist activity of nifedipine analogues containing 1-oxido-2-pyridyl in place of the 2-nitrophenyl moiety.

作者信息

Ramesh M, Matowe W C, Wolowyk M W, Knaus E E

机构信息

Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Canada.

出版信息

Drug Des Deliv. 1988 Dec;3(4):337-41.

PMID:3255335
Abstract

Analogues (5) of nifedipine (1a), in which the 2-nitrophenyl at position 4 is replaced by 1-oxido-2-pyridyl, were synthesized and evaluated as calcium channel antagonists using the muscarinic receptor-mediated Ca2+-dependent contraction of guinea pig ileal longitudinal smooth muscle. The replacement resulted in a significant loss of activity. In the case of the symmetrical dialkyl esters (5a-e), activity was enhanced by increasing the size of the alkyl ester substituents, the relative order of potency being i-Bu congruent to t-Bu greater than i-Pr greater than Et and Me. Our results show that the 1-oxido-2-pyridyl substituent is not a useful isostere of the 2-nitrophenyl moiety of nifedipine. In the synthetic work, Hantzsch condensation of 2-pyridinecarboxaldehyde 1-oxide (4) with equimolar quantities of alkyl acetoacetates (2) and alkyl 3-aminocrotonates (3) afforded dialkyl 1,4-dihydro-2,6-dimethyl-4-(1-oxido-2-pyridyl)-3,5-pyridinedicarboxylate s (5).

摘要

合成了硝苯地平(1a)的类似物(5),其中4位的2-硝基苯基被1-氧化-2-吡啶基取代,并使用毒蕈碱受体介导的豚鼠回肠纵行平滑肌钙依赖性收缩来评估其作为钙通道拮抗剂的活性。这种取代导致活性显著丧失。对于对称二烷基酯(5a-e),通过增加烷基酯取代基的大小可增强活性,效力的相对顺序为异丁基≡叔丁基>异丙基>乙基>甲基。我们的结果表明,1-氧化-2-吡啶基取代基不是硝苯地平2-硝基苯基部分的有用电子等排体。在合成工作中,2-吡啶甲醛1-氧化物(4)与等摩尔量的烷基乙酰乙酸酯(2)和烷基3-氨基巴豆酸酯(3)进行汉茨希缩合反应,得到1,4-二氢-2,6-二甲基-4-(1-氧化-2-吡啶基)-3,5-吡啶二甲酸二烷基酯(5)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验